Frank Krieg-Schneider

Frank Krieg-Schneider is an accomplished professional with extensive experience in the biotechnology and diagnostics industries. Currently serving as Chief Technology Officer at Mainz Biomed since August 2022, Frank Krieg-Schneider focuses on developing molecular genetic diagnostic solutions. As the founder of Krieg-Schneider Management Consulting, established in February 2019, Frank Krieg-Schneider assists young companies in the IVD industry. Previous roles include Vice President of Clinical Diagnostics at R-Biopharm AG and CEO at GNA Biosolutions, where groundbreaking molecular technology was developed. Frank Krieg-Schneider held several significant positions at QIAGEN from 1995 to 2015, including Vice President and Executive Director of Strategic Alliances, contributing to substantial revenue growth and the expansion of the OEM business. Frank Krieg-Schneider holds a Doctor of Philosophy (PhD) in Biotechnology from Johannes Gutenberg University Mainz.